Signal from the log
Chai Discovery
130 M$ · Series B · United States · Biotech
Société de San Francisco qui conçoit des molécules biologiques par intelligence artificielle. Son modèle Chai-2 génère des séquences d'anticorps sans partir d'exemples connus, avec des taux de succès que l'entreprise annonce cent fois supérieurs aux méthodes computationnelles antérieures. Le tour de 130 M$ valorise la société 1,3 milliard de dollars, chiffre qu'il ne faut pas confondre avec le montant levé.
Verified
Announced on , logged by the watch of 12 August 2026.
- Operation
- Funding round
- Announced amount
- 130 M$
- Stage
- Series B
- Country
- United States
- Sector
- Biotech
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by Oak HC/FT , General Catalyst , with OpenAI , Thrive Capital , Menlo Ventures , Dimension
Provenance
Source longevity
Logged on 12 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.